Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Non-Current Assets (2019 - 2025)

AVITA Medical's Other Non-Current Assets history spans 7 years, with the latest figure at $612000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 12.09% year-over-year to $612000.0; the TTM value through Dec 2025 reached $612000.0, up 12.09%, while the annual FY2025 figure was $612000.0, 12.09% up from the prior year.
  • Other Non-Current Assets reached $612000.0 in Q4 2025 per RCEL's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.2 million in Q2 2022 to a low of $122000.0 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $447750.0, with a median of $321000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: surged 20000.0% in 2021, then plummeted 77.02% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $201000.0 in 2021, then tumbled by 39.3% to $122000.0 in 2022, then surged by 190.98% to $355000.0 in 2023, then skyrocketed by 53.8% to $546000.0 in 2024, then increased by 12.09% to $612000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Other Non-Current Assets are $612000.0 (Q4 2025), $1.1 million (Q3 2025), and $839000.0 (Q2 2025).